EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Electrotrichogenic Device Promotes Hair Growth in Men With Androgenetic Alopecia: A Pilot Study

Samuel Jellard, Stephanie Moore, Carlos Andrés Chacón-Martínez iD

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Samuel Jellard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mane Biotech GmbH, Cologne, Germany. Hauptthemen laut MEDLINE: Alopecia, Hair, Electric Stimulation Therapy, Wearable Electronic Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgenetic alopecia (AGA) is the most common cause of hair loss globally, affecting millions of people, particularly men. Current treatments include FDA‐approved drugs and devices, but many patients experience side effects or suboptimal results. The niostem device is a new, wearable device that delivers low‐level electrical stimulation to promote hair growth. This pilot study aims to evaluate the efficacy and safety of the niostem device in male AGA patients.

Methods

A total of 21 male patients with AGA used the niostem device daily for 30 min over 6 months. Participants had not used any anti‐hair loss products within the 6 months preceding the start of the study. Hair density, thickness, and terminal hair counts were assessed at baseline, 3 months, and 6 months using trichoscopic measurements. Patient‐reported outcomes were recorded, and adverse events were monitored.

Results

The niostem device resulted in significant increases in hair count, with a 12% increase in total hair density at 3 months and a 19.3% increase at 6 months. Hair thickness also increased by 8.8% in 6 months. Terminal hair density improved significantly over time, with visible hair growth observed in the participants. No adverse events were reported.

Conclusions

The niostem device demonstrated a significant increase in hair density and hair thickness in male AGA patients, with no adverse effects. Further large‐scale studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaHairElectric Stimulation TherapyWearable Electronic DevicesHumansMalePilot ProjectsAdultMiddle AgedTreatment OutcomePatient Reported Outcome MeasuresYoung Adult

Stichwörter der Autor:innen

cosmetic dermatologyhair growthmale pattern baldness

Autor:innen und Institutionen

  • Mane Biotech GmbH, Cologne, Germany.
  • Surrey Trichology Clinic, Surrey, UK.

ORCID-Profile: Carlos Andrés Chacón-Martínez

Zitieren

APA

Jellard, S., Moore, S., & Chacón-Martínez, C. A. (2025). Novel Electrotrichogenic Device Promotes Hair Growth in Men With Androgenetic Alopecia: A Pilot Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70202

Vancouver

Jellard S, Moore S, Chacón-Martínez CA. Novel Electrotrichogenic Device Promotes Hair Growth in Men With Androgenetic Alopecia: A Pilot Study. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70202

BibTeX
@article{Jellard2025,
  author = {Jellard, Samuel and Moore, Stephanie and Chacón-Martínez, Carlos Andrés},
  title = {Novel Electrotrichogenic Device Promotes Hair Growth in Men With Androgenetic Alopecia: A Pilot Study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70202}
}
Kostenlos starten →